Press release
Idiopathic Pulmonary Fibrosis Treatment Market Projected to Reach USD 7.81 Billion by 2034, Growing at a 6.9% CAGR
Idiopathic Pulmonary Fibrosis Treatment Market
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide idiopathic pulmonary fibrosis treatment market. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by drug class, route of administration, distribution channel, and region in the study, which offers a comprehensive picture of the state of the market.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/idiopathic-pulmonary-fibrosis-treatment-market/request-for-sample
๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
Idiopathic pulmonary fibrosis (IPF) is a type of interstitial pneumonia characterized by progressive and irreversible lung fibrosis. The condition is defined by the development of scar tissue in the lungs, beginning at the edges and moving towards the center, resulting in breathing complications and inadequate oxygen supply to the body's tissues. Diagnosis involves chest imaging, lung biopsies, pulmonary function tests, and antibody tests. Two popular antifibrotic treatments are medications based on nintedanib and pirfenidone, which enhance lung function and reduce the chances of acute respiratory decline. They are commonly used with oxygen therapy and palliative care to offer comfort and enhance the patient's recovery.
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐๐ง๐ ๐๐ซ๐๐ง๐๐ฌ:
โข Older people are at higher risk of developing pulmonary fibrosis because they lose protective stem cells and pericytes as they age, which can cause fibroblast activation and growth. As the world's population gets older, the number of cases of idiopathic pulmonary fibrosis rises.
โข Improvements in diagnostic techniques are greatly contributing to the expansion of the idiopathic pulmonary fibrosis (IPF) treatment market. Enhanced imaging methods like high-resolution computed tomography (HRCT) allow for the earlier and more precise identification of IPF, making timely treatment easier.
๐๐จ๐ฉ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ:
The market is marked by fierce competition, and the leading companies rely on innovative technology, superior goods, and a strong brand identity to boost sales.
Here are the top companies in the idiopathic pulmonary fibrosis treatment market:
โข F. Hoffmann-La Roche Ltd
โข Boehringer Ingelheim International GmbH
โข Bristol-Myers Squibb Company
โข Medicinova, Inc
โข Merck & Co., Inc.
โข Galapagos NV
โข Novartis AG
โข Fibrogen, Inc.
โข Avalyn Pharma Inc.
โข Promedior, Inc.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐:
https://www.polarismarketresearch.com/industry-analysis/idiopathic-pulmonary-fibrosis-treatment-market/request-for-discount-pricing
๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐๐ข๐ฌ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:
According to regional analysis, North America held the largest revenue share in 2024 because of its advanced healthcare system, effective healthcare regulations and emphasis on research and development are also driving growth in the market in North America.
Also, during the projection period, Asia Pacific is projected to register a significant CAGR because of the increasing occurrence of idiopathic pulmonary fibrosis; increasing knowledge and improved diagnostic techniques are anticipated to drive market expansion in Asia Pacific throughout the forecast period.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
๐๐ฒ ๐๐ซ๐ฎ๐ ๐๐ฅ๐๐ฌ๐ฌ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐๐๐๐-๐๐๐๐)
โข Pirfenidone
โข Nintedanib
โข Interferon Gammato1b
โข Others
๐๐ฒ ๐๐จ๐ฎ๐ญ๐ ๐จ๐ ๐๐๐ฆ๐ข๐ง๐ข๐ฌ๐ญ๐ซ๐๐ญ๐ข๐จ๐ง ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐๐๐๐-๐๐๐๐)
โข Oral
โข Injectable
โข Others
๐๐ฒ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐๐ก๐๐ง๐ง๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐๐๐๐-๐๐๐๐)
โข Hospital Pharmacies
โข Retail Pharmacies
โข Others
๐๐ฒ ๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐๐๐๐-๐๐๐๐)
โข North America
โข Europe
โข Asia Pacific
โข Latin America
โข Middle East & Africa
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐ฆ๐จ๐ซ๐ ๐๐๐จ๐ฎ๐ญ ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐:
https://www.polarismarketresearch.com/industry-analysis/idiopathic-pulmonary-fibrosis-treatment-market/inquire-before-buying
๐๐๐ข๐จ๐ฉ๐๐ญ๐ก๐ข๐ ๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐๐ซ๐ฒ ๐ ๐ข๐๐ซ๐จ๐ฌ๐ข๐ฌ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โข Based on route of administration, the oral segment is anticipated to register a significant CAGR in the global market during the forecast period. This growth is attributed to its several advantages, including ease of use and potential of outpatient management.
โข By distribution channel, the hospital pharmacies segment accounted for the largest revenue share of the market in 2024 due to increasing hospitalization rates and the availability of specialized care for patients requiring advanced treatments.
โข In 2024, North America accounted for the largest revenue share of the global idiopathic pulmonary fibrosis treatment market due to its advanced medical infrastructure
โข The idiopathic pulmonary fibrosis treatment market in India is projected for significant growth during the forecast period due to the increased investments in its pharmaceutical manufacturing sector.
โข A few global key market players are F. Hoffmann-La Roche Ltd; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; Medicinova, Inc; Merck & Co., Inc.; Galapagos NV; Novartis AG; and Fibrogen, Inc.
๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
๐๐๐ฅ๐๐ซ๐๐๐ข๐จ๐ฅ๐จ๐ ๐ฒ ๐๐จ๐๐ญ๐ฐ๐๐ซ๐ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/teleradiology-software-market
๐๐๐๐๐ฅ๐ ๐๐จ๐ฅ๐๐๐ซ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/needle-holder-market
๐๐ญ๐๐ซ๐ข๐ฅ๐ ๐๐ง๐ฃ๐๐๐ญ๐๐๐ฅ๐ ๐๐จ๐ง๐ญ๐ซ๐๐๐ญ ๐๐๐ง๐ฎ๐๐๐๐ญ๐ฎ๐ซ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/sterile-injectable-contract-manufacturing-market
๐๐๐ฅ๐ฅ ๐๐ซ๐จ๐๐๐ฌ๐ฌ๐ข๐ง๐ ๐๐ง๐ฌ๐ญ๐ซ๐ฎ๐ฆ๐๐ง๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/cell-processing-instruments-market
๐๐ข๐ ๐ข๐ญ๐๐ฅ ๐-๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/digital-x-ray-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Idiopathic Pulmonary Fibrosis Treatment Market Projected to Reach USD 7.81 Billion by 2034, Growing at a 6.9% CAGR here
News-ID: 3725593 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Lactation Support Supplements Market to Sail to US$ 1,209.90 Million With a 6.5% โฆ
The lactation support supplements market is expected to gain market growth during the forecast period of 2025-2034. Polaris Market Research analyzes the market to account for USD 1,209.90 million by 2034 and is expected to register a CAGR of 6.5% in the above-mentioned forecast period. The market was valued at USD 643.04 million in 2024.
Market Overview:
Many modern parents who wish to benefit from breastfeeding strive to produce sufficient breast milkโฆ
Autoinjectors Market is Expected to Register a CAGR of 14.3% Surging Towards US$ โฆ
The autoinjectors market is expected to gain market growth during the forecast period of 2025 to 2034. Polaris Market Research analyzes the market to account for USD 31.20 billion by 2034 and is expected to register a CAGR of 14.3% in the above-mentioned forecast period. The market was valued at USD 8.22 billion in 2024.
Market Overview:
An autoinjector is a device designed to ease the self-administration of injectable medicines. By deliveringโฆ
Continuous Glucose Monitoring Device Market expected to reach USD 10.15 Billion โฆ
The Continuous Glucose Monitoring Device Market Is Expected To Gain Market Growth During The Forecast Period Of 2025-2034. Polaris Market Research Analyses The Market To Account For USD 10.15 Billion By 2034 And Is Expected To Register A CAGR Of 7.0% In The Above-Mentioned Forecast Period. The Market Was Valued At USD 5.17 Billion In 2024.
Market Overview
A continuous glucose monitor (CGM) approximates what the glucose level is periodically and keepsโฆ
Ovarian Cancer Market Projected to Reach USD 35.00 Billion by 2034, Growing at a โฆ
The global ovarian cancer market was valued at USD 4.11 billion in 2024. It is expected to reach USD 35.00 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 24.1% from 2025 to 2034.
Market Preface:
Ovarian cancer is the uncontrolled growth of abnormal cells in the ovaries. The cells proliferate rapidly and can invade and destroy healthy body tissues. Ovarian cancer commences when cells in or proximity to ovariesโฆ
More Releases for Idiopathic
Chronic Idiopathic Myelofibrosis Market 2022 | Detailed Report
The Chronic Idiopathic Myelofibrosis report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry.
The Chronic Idiopathic Myelofibrosis report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,โฆ
Idiopathic Membranous Nephropathy Treatment Market to Witness Significant Growth โฆ
Idiopathic membranous nephropathy a glomerular disease usually of abrupt onset and associated with the nephrotic syndrome. Membranous nephropathy occurs when the small blood vessels in the kidney (glomeruli), which filter wastes from the blood, become damaged and thickened. As a result, proteins leak from the damaged blood vessels into the urine (proteinuria).
R&D in idiopathic membranous nephropathy is expected to aid in growth of the idiopathic membranous nephropathy treatment market. Inโฆ
Global Idiopathic Scoliosis Treatment Market Size by Type (Infantile Idiopathic, โฆ
Global Idiopathic Scoliosis Treatmentโโโโโโโ Market Research report provides vital information related to the overall market and forecast from 2019 to 2026. This report includes the in-depth analysis of market size, share, growth, trends and regional demand and top layers the Idiopathic Scoliosis Treatmentโโโโโโโ Market. The major players dominating the market are focused upon throughout the by analyzing their revenue, their business summary, product segmentation along with the latest developments.
Get Sampleโฆ
Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Analysis, 2017
The study analyzed that the IPF pipeline comprised of 104 drug candidates, of which 19 drugs are in the Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. There are various drugs that are being developed as novel and promising therapeutics for the treatment of IPF.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/idiopathic-pulmonary-fibrosis-therapeutics-market
As per the findings of research, itโฆ
Juvenile Idiopathic Arthritis Therapeutics Market
JIA is also known as juvenile idiopathic arthritis and is the most common inflammatory arthritis of childhood, musculoskeletal pain is a common symptom in childhood and is usually benign and self-resolving. JIA is affected to children who are under age 17. Recognizing rare but treatable causes, including inflammatory, malignant and infectious etiologies, remains a constant challenge. According to the American College of Rheumatology, Juvenile idiopathic arthritis affects one in 1000โฆ
Chronic Idiopathic Constipation Market Research Report 2024
Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipationโฆ
